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Abstract: Adoption of a Mediterranean diet (MD) reduces cardiovascular disease (CVD) risk.
However, interventions to achieve dietary behaviour change are typically resource intensive.
Peer support offers a potentially low-cost approach to encourage dietary change. The primary
objective of this randomised controlled trial is to explore the feasibility of peer support versus a
previously tested dietetic-led intervention to encourage MD behaviour change, and to test recruitment
strategies, retention and attrition in order to inform the design of a definitive trial. A total of 75
overweight adults at high CVD risk who do not follow a MD (Mediterranean Diet Score (MDS ≤ 3))
will be randomly assigned to either: a minimal intervention (written materials), a proven intervention
(dietetic support, written materials and key MD foods), or a peer support intervention (group-based
community programme delivered by lay peers) for 12 months. The primary end-point is change in
MDS from baseline to 6 months (adoption of MD). Secondary end-points include: change in MDS
from 6 to 12 months (maintenance of MD), effects on nutritional biomarkers and CVD risk factors,
fidelity of implementation, acceptability and feasibility of the peer support intervention. This study
will generate important data regarding the feasibility of peer support for ease of adoption of MD in
an ‘at risk’ Northern European population. Data will be used to direct a larger scale trial, where the
clinical efficacy and cost-effectiveness of peer support will be tested.
Keywords: Mediterranean diet; behaviour change; peer support; cardiovascular disease;
public health
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1. Introduction
1.1. The Cardioprotective Benefits of a Mediterranean Diet
The traditional Mediterranean diet (MD), rich in fruit, vegetables, wholegrains, nuts, fish and
olive oil, and low in red meat and processed foods [1], is rated as the most likely dietary pattern
to offer protection against cardiovascular disease (CVD) [2]. This is supported by robust evidence
from epidemiologic studies [3–5], which have been subjected to meta-analysis [6]. Furthermore,
the evidence base is strengthened by the addition of randomised controlled trials (RCT) demonstrating
a clear benefit of increased MD adherence for primary and secondary CVD prevention. The Lyon Diet
Heart Study in patients with myocardial infarction, showed a significant 50–70% reduction in CVD
events in the MD intervention group compared with standard care [7]. The PREDIMED (Prevención
con Dieta Mediterránea) primary prevention trial, involving 7447 adults at high CVD risk, reported a
significant 30% reduction in CVD events in those consuming a MD supplemented with either olive oil
or nuts, compared to those consuming a low-fat control diet [8]. The cardio-protective mechanisms
of the diet are not fully understood; however, increased adherence appears to modify established
vascular risk factors including blood lipids, blood pressure, insulin resistance and inflammation [9,
10]. Emerging evidence also suggests that adopting a MD can have additional benefits for overall
longevity and chronic conditions, such as diabetes, cancer and Alzheimer’s disease [6]. The health
benefits offered by a MD appear to be attributable to biological interactions between different food
components rather than the effects of single nutrients [11]. Hence, this dietary pattern has been
proposed as a palatable and beneficial lifestyle change [12] and has been recommended as a healthy
eating pattern in the 2015–2020 dietary guidelines for Americans [13]. However, accessibility to foods
and sociocultural influences on food choice differ between countries and populations [14] and it is not
yet clear whether non-Mediterranean countries can adopt and maintain dietary behaviours consistent
with a traditional MD.
1.2. Peer Support as a Potential Strategy to Encourage Dietary Behaviour Change
Successful dietary change toward a MD is shown to be possible with resource intensive
interventions, usually delivered by health professionals [8,12,15,16]. Interventions of this nature
may be challenging to scale-up for wider public health benefit. One solution is to involve lay peers in
the delivery of dietary behaviour change programmes. This type of organised peer support offers an
alternative and potentially low-cost way of promoting dietary change [17] and capitalises on social
support networks between individuals to strengthen factors associated with successful behaviour
change, such as knowledge, self-efficacy and resilience [18,19].
There is a large body of literature on peer support for self-management of health behaviours
and disease conditions. However, the effectiveness of peer support as a sole method for changing
dietary behaviour is not entirely consistent. Some peer support interventions have demonstrated
significant improvements in diet quality [20–24] while other interventions show no effect [25,26].
Similarly, systematic reviews of the effectiveness of peer support to improve vascular and diabetes
outcomes have been unable to draw firm conclusions [27,28]. The effectiveness of peer support
interventions is difficult to determine owing to substantial between study heterogeneity in study
design, study population, sample size and outcome measures. In addition, there is considerable
variation in the format, content and intensity of peer support provided, with few studies reporting
behavioural strategies used to encourage behaviour change or the fidelity of intervention delivery.
Overall, peer support could be a promising strategy for promoting MD behaviour change [16] but
further well-designed trials are required to determine effectiveness.
1.3. Development of a Tailored Peer Support Intervention
Evidence suggests that lifestyle interventions informed by theoretically-driven behaviour change
models are more successful and lead to stronger and more sustained changes [29]. Therefore, in
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accordance with the Medical Research Council framework for developing and evaluating complex
interventions to improve health [30] and the Behaviour Change Wheel [31], we developed a
theory-based, tailored peer support intervention delivered in a community setting to encourage
dietary behaviour change in a Northern European population at high CVD risk. The process used
to develop the intervention involved both a literature review [32,33] and qualitative research with
our target high CVD risk population [34,35]. The intervention is underpinned by the social support
theoretical model, defined as ‘the process through which social relationships might promote health
and well-being’ [19]. Within this model, we postulated that the peer support intervention would
provide informational, emotional and appraisal support to encourage dietary change towards a
MD. We also incorporated psychological theories of behaviour change at the interpersonal e.g.,
Social Cognitive Theory, and intrapersonal level e.g., Health Beliefs Model. It is unclear how peer
support can change dietary behaviour towards a MD, however potential mechanisms are likely
to be via strengthening of variables known to support behaviour change [18], for example, social
support, self-efficacy, self-regulation, problem-solving, knowledge, attitudes and skill acquisition.
We incorporated strategies in the intervention to enhance these variables based on the Capability,
Opportunity, Motivation, Behaviour (COM-B) model to specifically address identified barriers to
adopting a MD in our target population [31,34].
1.4. Aim
This paper describes the protocol for the TEAM-MED study (Trial to Encourage Adoption and
Maintenance of a MEiterranean Diet) that aims to explore the feasibility of peer support versus
a previously tested dietitian-led intervention to encourage MD behaviour change [8], and to test
recruitment strategies, retention and attrition, to inform the design of a definitive trial where the
clinical and cost-effectiveness of the peer support intervention will be tested.
2. Materials and Methods
2.1. TEAM-MED Objectives
The objectives to meet the study aim are to:
• Estimate and compare the variability of Mediterranean Diet Score (MDS) from baseline to
6 months and from 6 months to 12 months between the peer support intervention and other
intervention groups
• Estimate and compare the variability of biochemical markers of nutritional status and health
markers over the course of the intervention, as for MDS, between the peer support intervention
and other intervention groups
• Test recruitment strategies, retention, attrition rates
• Estimate the sample size for a large-scale trial
Methods to achieve these objectives are described in detail below. Further study objectives related
to the planned process evaluation (to be published separately) are to:
• Test the validity of the theoretical model underpinning the peer support intervention
• Evaluate the training and support provided to peer supporters to deliver the intervention
• Determine fidelity of implementation and acceptability of the intervention
• Assess outcome data collection processes within the pilot trial, including those to explore
mediators and moderators of MD adherence and cost-effectiveness
• Explore reasons for withdrawal for study participants and peer supporters recruited to deliver
the peer support intervention
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2.2. Design
TEAM-MED is a 12 month pilot parallel group RCT designed to evaluate the feasibility of
a community-based peer support intervention to encourage adoption and maintenance of a MD,
in comparison to a proven dietetic-led intervention [8] and a minimal intervention (control group),
in adults at high CVD risk in Northern Ireland. Ethical approval has been received from the Office
for Research Ethics Committees Northern Ireland (HSC RECA; ref 13/NI/0152) who will also review
any changes made to the protocol. The study protocol is registered on ControlledTrials.com (ID
no. ISRCTN68779848). Informed written consent for study procedures and collection, handling and
storage of biological samples will be obtained from all study participants by the study researcher.
An overview of the study design is shown in Figure 1 and a summary is reported using the
SPIRIT checklist (Table S1). Following a screening appointment, eligible participants will be block
randomized (using a computer-generated random-number sequence) to either: (i) a peer support
intervention; (ii) a dietetic-led intervention; or, (iii) a minimal intervention. Participants will be
informed of their allocated group by the researcher after baseline data is collected. It will not be
possible to blind study researchers or participants to the allocated intervention group, however,
laboratory and data analysis and assessment of primary outcome will be carried out by an investigator
blinded to treatment allocation.
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Figure 1. Overview of Trial to Encourage Adoption and Maintenance of a MEditerranean Diet
(TEAM-MED) study design. MD: Mediterranean diet.
The three TEAM-MED intervention groups (peer support, dietitian-led support and minimal
support) as discussed in Section 2.4, vary in the intensity and nature of support provided to participants
to encourage adoption of dietary behaviours consistent with a MD. The target MD behaviours for
this study are based on the PREDIMED study [8] adapted for the current population [34] and include:
preferential consumption of wholegrain cereal foods, fruits ≥ 2 portions (160 g)/day, vegetables ≥
3 portions (240 g)/day, olive/rapeseed oils ≥ 4 tbsp. (60 mL)/day and/or Monounsaturated Fatty
Acid (MUFA)-rich spreads ≥ 3 tsp. (15 g)/day, nuts ≥ 3 handfuls (90 g)/week, legumes ≥ 3 portions
(240 g)/week, fish ≥ 3 servings (420 g)/week, red meat ≤ 2 servings (300 g)/week, processed meat
≤ 1 serving (150 g)/week, confectionary ≤ 3 servings/week, alcohol (if consumed) 125–375 mL ≥
3 days/week.
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The inclusion of rapeseed oil as an alternative to olive oil was a pragmatic decision taken to
address specific barriers to olive oil intake e.g., cost, taste and cultural differences in food choice that
were identified in our target population [32]. Rapeseed oil is a more familiar culinary oil with a similar
fatty acid profile albeit with lower polyphenol and bioactive content compared to olive oil.
Specific behaviour change techniques derived from published taxonomies [36,37] are incorporated
in each TEAM-MED intervention to promote MD behaviour change, as shown in Table 1. The duration
of the intervention is one year and study assessments will be conducted at baseline and at 3-, 6- and
12-month follow up.
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Table 1. Behaviour Change Techniques used to encourage dietary change towards a Mediterranean diet.
TEAM-MED
Intervention Groups BCTs (n)
BCT Label (from BCT Taxonomy 1 or
CALO-RE 2)
BCT Definition Example of BCT Delivery in theIntervention Groups
Group 1: Peer support 18
Provide information on consequences
of behaviour in general 2
Information about the relationship between the behaviour
and its possible or likely consequences in the general case,
usually based on epidemiological data, and not
personalised for the individual
Peer supporters show a short video clip to group
members demonstrating the health effects of a MD
Provide normative behaviour about
others’ behaviour 2
Involves providing information about what other people
are doing i.e., indicates that a particular behaviour or
sequence of behaviours is common or uncommon
amongst the population or amongst a specified
group—presentation of case studies of a few others is not
normative information.
Peer supporters provide information about current
MD adherence in Northern European populations
Goal setting (Behaviour) 1,2
Set or agree on a goal defined in terms of the behaviour to
be achieved
Peer supporters support members to set MD goals
at each group session based on the session topic
Goal setting (outcome) 1,2
Set or agree on a goal defined in terms of a positive
outcome of wanted behaviour
Group members are encouraged within their
personal planners to define what they want to
achieve by taking part in the peer support groups,
e.g., target weight loss, or decreasing to target
blood pressure level etc.
Action planning 1,2
Prompt detailed planning of performance of
the behaviour
Peer supporters support members to set MD goals
that are easy to measure, something that can be
achieved, small and meaningful (i.e., SMART
goals) at each group session
Barrier identification/problem solving
1,2
Analyse, or prompt the person to analyse, factors
influencing the behaviour and generate or select strategies
that include overcoming barriers and/or
increasing facilitators
Peer supporters facilitate group discussion to
identify barriers/challenges in achieving personal
MD goals and assist members to select the best
strategies to overcome these
Set graded tasks 1,2
Set easy-to-perform tasks, making them increasingly
difficult, but achievable, until behaviour is performed
Increasing adherence to a MD is broken down into
smaller tasks within written materials, e.g., food
swaps are listed separately for each major
MD component
Prompt review of behavioural goals 2
Involves a review or analysis of the extent to which
previously set behavioural goals were achieved
Each group session will provide an opportunity
for general progress review in terms of behaviour
Prompt self-monitoring of behaviour 2
The person is asked to keep a record of specified
behaviour(s) as a method for changing behaviour.
Group members are given personal planners to
monitor their daily/weekly progress in achieving
set MD goals and to allow them to record any
barriers/challenges they experience
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Table 1. Cont.
TEAM-MED
Intervention Groups BCTs (n)
BCT Label (from BCT Taxonomy 1 or
CALO-RE 2)
BCT Definition Example of BCT Delivery in theIntervention Groups
Group 1: Peer support 18
Prompt self-monitoring of
behavioural outcome 2
The person is asked to keep a record of specified measures
expected to be influenced by the behaviour change
Group members are encouraged to log and
monitor their weight, blood pressure etc. in
personal planners
Provide information on when and
where to perform the behaviour 2
Involves telling the person about when and where they
might be able to perform the behaviour
Recipe books and written information provide
information regarding different meals, and also
eating out as well as eating in the home
Provide instruction on how to
perform behaviour 1,2
Involves telling the person how to perform behaviours,
either verbally or in written form.
Peer supporters provide group members with a
booklet and a visual guide (MD food pyramid) to
provide instruction on the types and proportions
of food components in a MD
Model/demonstrate the behaviour 1,2
Provide an observable sample of the performance of the
behaviour, directly in person or indirectly
Peer supporters show a short video clip to group
members demonstrating preparation and
consumption of a MD on a budget and food
tasting sessions form part of peer group meetings
Use of follow-up prompts 2
Intervention components are gradually reduced in
intensity, duration and frequency over time, e.g., letters or
telephone calls instead of face-to-face and/or provided at
longer time intervals
Group sessions decrease in frequency after
six months
Plan social support/social change 2
Involves prompting the person to plan how to elicit social
support from other people to help him/her achieve their
target behaviour/outcome.
Group members are encouraged to support and
contact each other between group sessions
Relapse prevention/coping planning 2
This relates to planning how to maintain behaviour that
has been changed. The person is prompted to identify in
advance situations in which the changed behaviour may
not be maintained and develop strategies to avoid or
manage those situations
One group session (session nine) is dedicated to
maintenance of dietary change and
relapse prevention
Biofeedback 1
Provide feedback about the body using an external
monitoring device as part of a behaviour change strategy
Peer supporters offer individual feedback on
blood pressure and weight measurements at each
group session
Social support 1
Advise on, arrange or provide social support or
non-contingent praise or reward for performance of the
behaviour
Peer supporters and group members provide
positive encouragement and support to each-other
to adopt new MD behaviours
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Table 1. Cont.
TEAM-MED
Intervention Groups BCTs (n)
BCT Label (from BCT Taxonomy 1 or
CALO-RE 2)
BCT Definition Example of BCT Delivery in theIntervention Groups
Group 2:
Dietitian-led support 20
Motivational interviewing 2,*
This is a clinical method including a specific set of
techniques involving prompting the person to engage in
change talk in order to minimise resistance and resolve
ambivalence to change
Participants attend individual motivational
interviewing delivered by a trained dietitian
Provide information on consequences
of behaviour in general 2
Information about the relationship between the behaviour
and its possible or likely consequences in the general case,
usually based on epidemiological data, and not
personalised for the individual
Dietitian shows a short video clip demonstrating
the health effects of a MD within the structured
group education sessionHealth consequences of
MD also detailed in educational material
Provide information on consequences
of behaviour to the individual 2
Information about the benefits and costs of action or
inaction to the individual or tailored to a relevant group
based on that individual’s characteristics
Discussion of dietary change to encourage
adherence to a MD occurs specifically based on
individual’s current level of adherence, and with
knowledge of their CVD risk score
Provide normative behaviour about
others’ behaviour 2
Involves providing information about what other people
are doing i.e., indicates that a particular behaviour or
sequence of behaviours is common or uncommon
amongst the population or amongst a specified
group—presentation of case studies of a few others is not
normative information.
Dietitian provides information about current MD
adherence in Northern European populations
Goal setting (Behaviour) 1,2
Set or agree on a goal defined in terms of the behaviour to
be achieved
Discussed during motivational interview
with dietitian
Goal setting (outcome) 1,2
Set or agree on a goal defined in terms of a positive
outcome of wanted behaviour
Discussed during motivational interview
with dietitian
Action planning 1,2
Prompt detailed planning of performance of the
behaviour
Discussed during motivational interview
with dietitian
Set graded tasks 1,2
Set easy-to-perform tasks, making them increasingly
difficult, but achievable, until behaviour is performed
Increasing adherence to a MD is broken down into
smaller tasks within educational materials, e.g.,
food swaps are listed separately for each major
MD component Reinforced by dietitian in group
education session and in individual session
Provide information on when and
where to perform the behaviour 2
Involves telling the person about when and where they
might be able to perform the behaviour
Recipe books and written information provide
information regarding different meals, and also
eating out as well as eating in the home
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Table 1. Cont.
TEAM-MED
Intervention Groups BCTs (n)
BCT Label (from BCT Taxonomy 1 or
CALO-RE 2)
BCT Definition Example of BCT Delivery in theIntervention Groups
Group 2:
Dietitian-led support 20
Provide instruction on how to perform
behaviour 1,2
Involves telling the person how to perform behaviours,
either verbally or in written form.
Practical support around shopping lists, recipes,
food storage and preparation given within
educational material
Barrier identification/problem
solving 1,2
Analyse, or prompt the person to analyse, factors
influencing the behaviour and generate or select strategies
that include overcoming barriers and/or increasing
facilitators
Discussion about challenges in meeting dietary
goals and developing strategies to overcome these
in group education session
Prompt review of behavioural goals 2
Involves a review or analysis of the extent to which
previously set behavioural goals were achieved
Individual progress review and feedback provided
at end of group education session
Prompt self-monitoring of behaviour 2
The person is asked to keep a record of specified
behaviour(s) as a method for changing behaviour
Plan to monitor progress in achieving goals
developed during motivational interview
Provide feedback on performance 2
This involves providing the participant with data about
their own recorded behaviour
Individual progress review and feedback provided
at end of group education session
Model/demonstrate the behaviour 1,2
Provide an observable sample of the performance of the
behaviour, directly in person or indirectly
Video clip demonstrating preparation and
consumption of a MD on a budget shown in group
education session
Plan social support/social change 2
Involves prompting the person to plan how to elicit social
support from other people to help him/her achieve their
target behaviour/outcome.
Discussion of support around family structure and
food purchasing/preparation included in
motivational interview and individual progress
review.
Social support encouraged through participation
in group education session with other participants.
Relapse prevention/coping planning 2
This relates to planning how to maintain behaviour that
has been changed. The person is prompted to identify in
advance situations in which the changed behaviour may
not be maintained and develop strategies to avoid or
manage those situations.
Challenging situations discussed during both
motivational interview and group
education session
Commitment 1
Ask the person to affirm or reaffirm statements indicating
commitment to change the behaviour
Affirmation of personal dietary goals sought
during motivational interview
Credible source 1
Present verbal or visual communication from a credible
source in favour of or against the behaviour
Both motivational interview and group education
session delivered by trained dietitian
Adding objects to the environment 1
Add objects to the environment in order to facilitate
performance of the behaviour Key foods delivered to participants
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Table 1. Cont.
TEAM-MED
Intervention Groups BCTs (n)
BCT Label (from BCT Taxonomy 1 or
CALO-RE 2)
BCT Definition Example of BCT Delivery in theIntervention Groups
Group 3:
Minimal support 4
Provide information on consequences
of behaviour in general 2
Information about the relationship between the behaviour
and its possible or likely consequences in the general case,
usually based on epidemiological data, and not
personalised for the individual
Health consequences of MD detailed in
educational material
Set graded tasks 1,2
Set easy-to-perform tasks, making them increasingly
difficult, but achievable, until behaviour is performed
Increasing adherence to a MD is broken down into
smaller tasks within written materials, e.g., food
swaps are listed separately for each major MD
component
Provide information on when and
where to perform the behaviour 2
Involves telling the person about when and where they
might be able to perform the behaviour
Recipe books and written information provide
information regarding different meals, and also
eating out as well as eating in the home
Provide instruction on how to
perform behaviour 1,2
Involves telling the person how to perform behaviours,
either verbally or in written form.
Practical support around shopping lists, recipes,
food storage and preparation given within
educational material
BCT = Behaviour Change Techniques derived from published taxonomies (see ref. [36] 1, [37] 2); * Motivational Interview is delivered by a trained Dietitian and centred on the individual
therefore listed BCTs are considered core within the intervention but additional BCTs are likely to be used to elicit dietary behaviour change at the individual level. TEAM-MED: Trial to
Encourage Adoption and Maintenance of a MEditerranean Diet. MD: Mediterranean diet.
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2.3. Study Participants
2.3.1. Participant Recruitment
We aim to recruit 75 male/female participants aged 40 years or more from hospital outpatient
clinics, GP surgeries and the general population. Potential participants will attend a dedicated research
facility at Queen’s University Belfast for a 45-min screening appointment conducted by a study
researcher. A questionnaire to record demographics, health and medical history (including medications
and supplement usage) and stage of dietary change towards a MD [38], will be used together with
CVD risk prediction charts [39] and an assessment of participant’s baseline MD adherence using an
existing 14-item questionnaire from the PREDIMED study [8] and modified to reflect the Northern
European diet to assess study eligibility.
2.3.2. Inclusion Criteria
Participants will be considered eligible to enrol in the study if they are overweight (BMI > 27 and
≤ 45 kg/m2), aged 40 years or more, have low adherence to a MD (MDS ≤ 3) and a combination of
risk factors which places them at high total risk (estimated multifactorial CVD risk ≥ 20% over ten
years) of developing atherosclerotic CVD for the first time.
2.3.3. Exclusion Criteria
Participants will not be eligible to enrol in the study if they have established diabetes mellitus,
CVD or a medical condition or dietary restriction(s) that would substantially limit their ability to
complete the study requirements, have an excessive alcohol consumption (>28 Units/week men or
>21 Units/week women), have a low predicted likelihood to change dietary habits or are unable to
provide informed consent.
2.3.4. Peer Supporters
Peer supporters (lay participants and/or community health workers) will be recruited from the
general public and from local community networks, volunteer websites and health centres. Two peer
supporters will be allocated to each group formed within the peer support intervention. It is envisaged
that one peer supporter will have been successful in making positive changes to their diet and the
other will be familiar with community networks and group facilitation. Potential peer supporters will
undergo study eligibility screening similar to that described for study participants above, and an
additional screening interview, conducted by two members of the study team, to determine their
suitability and commitment to deliver the peer support intervention. In total, 12 peer supporters will
be recruited and trained, which is more than required to successfully deliver the proposed intervention.
However, access to a pool of trained peer supporters will allow any setbacks in study implementation
to be quickly addressed, for example, withdrawal of peer supporters from the study.
2.3.5. Peer Supporter Training
TEAM-MED peer supporters will attend two full training days delivered by qualified experts in
dietary behaviour change and group facilitation skills. The training aims to equip peer supporters with
knowledge (e.g., MD components, role of a peer supporter and behavioural strategies to support dietary
change), confidence (e.g., practical experience in delivering the intervention resources) and skills (e.g.,
group facilitation and communication skills) to effectively deliver the peer support intervention.
Peer support training will be interactive and informal, with emphasis on the provision of social
support to encourage positive dietary change. An outline of peer supporter training components is
shown in Table 2. Peer supporters will complete a knowledge questionnaire post-training, which will
be used to determine individual competence to deliver the peer support intervention. A certificate
will be given to those peer supporters who are successful in completing the training course (>75%
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questionnaire score). If competency to deliver the intervention is not achieved at this stage, further
training will be offered to peer supporters via refresher day training and competency will be reassessed
by administering the post-training questionnaire (as outlined above).
Table 2. Overview of Peer supporter training programme delivered over two consecutive days.
Day Training Components
One (7 h)
Mediterranean Diet food components, health benefits and pyramid model
Role of a peer supporter
Group intervention format, content and introduction to resources
Practical dietary advice to overcome barriers to eating a Mediterranean diet
Weight and blood pressure measurement workshop including provision of feedback
Maintaining study documentation for group sessions
Two (7 h)
Social support in a group setting to encourage dietary change
Group facilitation skills
Delivering group resources
Handling difficult group situations
2.3.6. Peer Supporter Support
Peer supporters will be provided with ongoing support from the study team during
implementation of the intervention. A detailed training manual (‘TEAM-MED peer supporter manual’)
will be provided to support delivery of the group intervention. The study team will promote ongoing
communication between paired peer supporters to plan individual roles for group session delivery.
Peer supporters will receive one scheduled telephone call from a researcher after individual group
sessions to discuss any challenges or difficulties they may have experienced. In addition, all trained
peer supporters will have an opportunity to meet as a group on at least one occasion during the
intervention period, where informal discussion and sharing of experiences will be encouraged.
Peer supporters will not be formally paid for their role but will receive reimbursement of travel
costs incurred to deliver the intervention. They will also be provided with a pre-paid smart phone to
facilitate communication with the study team, peer supporters and group participants.
2.4. TEAM-MED Intervention Groups
2.4.1. Group 1: Peer Support (n = 25)
A full description of the theory-based, tailored peer support intervention is published
separately [30] and outlined below. Participants allocated to this intervention will be scheduled
to attend a group programme delivered by two trained peer supporters comprising 11 group sessions
over the 12-month period. Groups will involve up to 10 study participants who will meet in a
convenient community setting, such as a private room in a community centre. Each group session
is expected to last up to 2-h and will include a brief (10–15 min) MD and/or behavioural education
component delivered by peer supporters and designed to provide a focus for group discussion.
The group topics include: ‘health benefits of a MD’, ‘changing fat intake’, ‘eating more wholegrain’
and ‘eating a seasonal MD’. Practical food demonstrations (via food tasting sessions) are included
in four group sessions. A personal weigh-in and blood pressure measurement will be available in
each session, with feedback offered by a peer supporter. Participants will be supported with written
MD educational materials, suggested meal plans, shopping lists and seasonal recipe books developed
specifically for the study to support MD behaviour change. In addition, a personal workbook will
be given to participants at the beginning of the group programme to facilitate dietary goal-setting
and self-monitoring of personal dietary goals. Participants are encouraged to maintain contact with
other group members and peer supporters between sessions (via telephone, text messaging and/or
face-to-face meetings) to promote social support and group cohesion.
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2.4.2. Group 2: Dietitian-Led Support (n = 25)
The dietitian-led intervention is based on that reported in the PREDIMED trial and shown to
be effective in achieving increased adherence to a MD [8]. At baseline, participants will attend an
individual face-to-face 90-min motivational interview with a study dietitian. Personal MD dietary
goals will be agreed and participants will receive written MD educational materials, suggested meal
plans, shopping lists and seasonal recipes identical to those suggested to those in the other intervention
groups. Participants will also be given key MD foods for daily consumption based on their personal
preference for either:
• 50 mL extra virgin olive oil (EVOO) or,
• 30 g nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) or,
• Combination of both (25 mL EVOO plus 15 g nuts (8 g walnuts, 3.5 g almonds and 3.5 g hazelnuts))
Participants will be scheduled to attend a 2-h quarterly (3-, 6-, 9- and 12-months) structured
group education session led by the dietitian, with up to four other study participants. The four group
session topics are: ‘changing to a MD’, ‘enjoying fruit and vegetables’, ‘eating more wholegrain’ and
‘continuing to eat a MD’. Seasonal recipe books, suggested meal plans and shopping lists will be
discussed at each session. The dietitian will then provide an individual 15-min progress review and
feedback after each group session. Throughout the intervention period, and between group sessions,
participants will have unlimited telephone/email contact with the dietitian for on-going support to
optimise compliance with the intervention.
2.4.3. Group 3: Minimal Support (Control) (n = 25)
Participants allocated to this group will receive the full TEAM-MED study written MD educational
materials, suggested meal plans, shopping lists and seasonal recipe books at baseline. No further
support will be provided. Participants will be offered an individual appointment with a researcher for
personal MD advice at the end of the intervention period.
3. Results
3.1. Outcomes
TEAM-MED will evaluate feasibility of the peer support intervention, in comparison to different
methods of providing dietary support, to change dietary behaviour toward a MD. Target behaviour
change for the intervention is defined as a ≥ 3-point increase in MDS from baseline to 6 months
(adoption) as this change is likely to be both achievable by the target population [15] and clinically
important [40]. We will also evaluate change in MDS from 6 to 12 months i.e., maintenance of MD
behavioural changes.
The variability data on change in MDS in response to the peer support intervention from baseline
to 6 months will inform the sample size for a larger study. TEAM-MED will explore indicative
effects of the intervention on CVD risk factors (e.g., body weight, blood pressure, fasting lipid profile,
inflammatory markers) and markers of diabetes risk (blood glucose and glycated haemoglobin (HbA1c)
levels) over the 12 months to inform the outcomes for a future definitive trial that will aim to assess
clinical effectiveness of the peer support intervention for cardiometabolic health. Possible mediators
of MD behaviour change in response to the intervention will also be explored as well as contextual
factors that could influence implementation of the intervention or moderate the study outcomes.
TEAM-MED will determine recruitment and retention rates, evaluate data collection methods for
outcomes and assess participant acceptability of the peer support intervention and acceptability of
changing dietary behaviour towards a MD. The full methodology used for process evaluation will be
presented in a separate manuscript.
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3.2. Study Measures
Study assessments will be conducted face-to-face at a dedicated research facility by a study
researcher at baseline, 3-, 6- and 12-months. Each assessment visit will follow strict standardised
operating procedures and last approximately 3.5 h. Table 3 outlines the study outcome measurements
and data collection methods to be used at each specified time-point. These are discussed in more
detail below.
3.2.1. Primary Outcome—MD Behaviour Change
A 14-item MDS questionnaire based on a similar questionnaire used in PREDIMED [8] and
adapted to incorporate food choices in a Northern European population, will be used to determine
MD adherence and ease of adoption of dietary behaviours consistent with a MD (see Table S2).
Overall dietary intake will be assessed using a 4-day food record at each time-point. Participants will
be given full instruction on how to complete the food record and asked to record all food/beverage
items at the time of consumption. Furthermore, nutrient biomarkers will be used to assess MD
compliance as discussed in Section 3.2.3.
3.2.2. Clinical Measures
Blood pressure (mmHg) will be measured in the dominant arm, after a 5-min rest in a seated
position, using a calibrated automated sphygmomanometer (Omron M5-1, OMRON Healthcare UK
Ltd., Milton Keynes, UK). Three separate blood pressure measurements will be recorded over a
five-minute period and summary systolic and diastolic blood pressure will be calculated from the
second and third readings [41]. Anthropometric measurements will be made in light clothing without
footwear using standard techniques. Standing height will be measured to the nearest 0.1 cm using a
wall-mounted stadiometer. Body weight will be measured using a calibrated digital weighing scale
(Tanita HS-301, Tanita, Yiewsley, UK) to the nearest 0.1 kg. Waist and hip circumference will be
measured using a flexible tape and recorded to the nearest 0.1 cm.
3.2.3. Biochemical Measures
A fasting blood sample will be obtained at each study visit using standard procedures by a
trained phlebotomist. Samples will be centrifuged at 3000 rpm for 15 min within two hours of
collection and stored in aliquots at −80 ◦C until analysis. A panel of nutrient biomarkers will be
measured in plasma/serum samples to reflect the MDS food group targets and overall compliance
with the MD in the intervention groups. Nutrient biomarkers will include: serum carotenoids and
serum vitamin E by high performance liquid chromatography with diode array detection [42], plasma
vitamin C by fluorimetric assay [43] and plasma fatty acids by gas chromatography [44,45]). A broad
range of biochemical measures will be assessed to provide indicative effects of the intervention on
cardiometabolic health and will include: fasting plasma glucose and 2-h plasma glucose (after a 75 g
oral glucose load) measured using an automated glucose oxidase method using a Beckman Glucose
Analyzer 2, as well as HbA1c and a fasting lipid profile measured using commercially available kits on
an ILab-600 biochemical analyzer (Instrumentation Laboratory, Warrington, UK). A spot non-fasted
urine sample will be obtained during the study visit for long term storage and future determination of
nutritional and CVD biomarkers.
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Table 3. TEAM-MED outcome measures and data collection methods.
Outcome Domain to Be Measured Data Collection Method(s) Baseline 3Months
6
Months
12
Months
Diet
MD adherence 14-item MDS questionnaire [8] 2
√ √ √ √
Dietary intake Food record (4-day)
√ √ √ √
Clinical &
biomarker
Nutritional biomarkers Venepuncture (fasting blood
sample)
OGTT
√ √ √ √
Impaired glucose tolerance
√ √ √ √
HbA1C
√ √ √ √
Blood pressure Clinic measured [41]
√ √ √ √
Nutrition and CVD
markers Urine sample (spot fasting sample)
√ √ √ √
Weight Digital scales
√ √ √ √
Height Stadiometer
√ √ √ √
Waist circumference Flexible tape
√ √ √ √
Mediators
of diet
behaviour
change
MD knowledge Nutrition knowledge questionnaire[47] 2
√ √ √ √
Readiness to change Stage of dietary changequestionnaire [38]
√ √ √ √
Perceived barriers to MD Eating habits questionnaire 1
√ √ √ √
Self-efficacy Questionnaire [48]
√ √ √ √
Social support Questionnaire [46] 2
√ × √ √
Problem solving ability Questionnaire [20] 2
√ √ √ √
Intervention
Moderators
Physical activity RPAQ questionnaire [49,50]
√ √ √ √
Smoking, alcohol,
medication use Questionnaire
1 √ √ √ √
Health beliefs Health belief questionnaire [51] 2
√ √ √ √
Health-related Quality of
Life SF-36 [52]; EQ-5D-3L [53]
√ √ √ √
Diet-related Quality of life Questionnaire [54] 2
√ √ √ √
Mood Questionnaire [55]
√ √ √ √
Self-esteem Self-esteem questionnaire [56]
√ √ √ √
1 Developed for TEAM-MED; 2 Modified for TEAM-MED. TEAM-MED: Trial to Encourage Adoption and
Maintenance of a MEditerranean Diet. MD: Mediterranean diet. MDS: Mediterranean Diet Score. OGTT: Oral
Glucose Tolerance Test. CVD: Cardiovascular disease. RPAQ: Recent Physical Activity Questionnaire.
3.2.4. Mediators of MD Behaviour Change
Several questionnaires will be administered at each study assessment time-point to explore
potential mediators of MD behaviour change. Social support will be assessed, across dimensional
scales, stress scales, different sources of support and types of support including informational, practical
and emotional support, using a modified social support inventory questionnaire previously used
in the Mediterranean Lifestyle Programme (MLP) intervention [46]. Problem-solving ability will be
assessed using an adapted version of a problem-solving questionnaire also used in the MLP [20]
(Dr. D. Toobert, personal communication). Additional questionnaires will be used to assess MD
knowledge [47], barriers to MD consumption (based on qualitative research with target population [34]
and self-efficacy to change dietary behaviour [48] adapted specifically to determine self-efficacy for
change in MD behaviours for the current study.
3.2.5. Intervention Moderators
Individual demographics, medication use and smoking status will be determined using a
questionnaire developed for the study. Physical activity will be assessed using a validated Recent
Physical Activity Questionnaire (RPAQ) [49,50]. Health beliefs will be investigated using a previously
validated questionnaire based on components of the Health Belief Model [51] and modified for the
present study. Several questionnaires will also be used to assess psychosocial well-being as potential
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moderators of MD behaviour change. The Rand 36-item (SF-36) validated questionnaire [52] will be
used to assess self-reported quality of life and the ED-5Q-3L validated questionnaire will be used to
determine generic health status [53]. A 34-item questionnaire (adapted for use in our population) will
be used to report diet-related quality of life (adapted from [54]). Self-reported mood will be determined
using the Positive and Negative Affect Schedule (PANAS) [55] questionnaire comprising two 10-item
mood scales. Self-esteem will be assessed using a validated 10-item questionnaire [56].
3.2.6. Evaluation of Recruitment and Study Attrition Rates
Study records completed by the research team will provide quantitative data on participant
recruitment rates from different sources, recruitment of peer supporters, withdrawal from the study
and reported reasons for withdrawal. Data will be used to evaluate recruitment strategies and estimate
attrition and retention rates.
3.3. Power and Sample Size
A primary objective of TEAM-MED is to determine change in MDS in response to the peer support
intervention from the target population and generate variability data to estimate sample size for a
definitive trial. However, we were able to calculate likely power for the study using data generated
in a previous intervention trial of patients with existing CVD [15]. Based on the MDS changes in the
behavioural counselling group of that trial, that showed standard deviations of 1.3 from baseline to
6 months, a study of 25 subjects per group would have approximately 90% power to detect a difference
between treatment groups in mean MDS change from baseline to 6 months of 1.4 units. This assumes a
30% dropout rate during the study period. Corresponding standard deviation for vitamin C change
(which is an indicator of fruit and vegetable intake and therefore may be one biomarker associated
with adherence to the MD) is 13.9 µmol/L and the difference in mean vitamin C change that could be
detected with approximately 90% power is 15 µmol/L. Given that TEAM-MED is evaluating a different
intervention to encourage MD adherence than that used previously, and in a different population,
the data generated here will provide a more reliable sample size calculation for a definitive study.
3.4. Statistical Analyses
Study data will be handled according to the Data Protection Act and will be anonymised and
archived in password-protected study databases. Data entry will be performed by trained researchers.
Data will be screened, cleaned and validated by the study team by performing summary statistical
checks for frequency distributions, missing data and outlier detection. The final dataset for analysis
will be approved by the study statistician. Data analysis will be conducted using SPSS version
23.0. Descriptive statistics will be provided for each of the three intervention groups at baseline
and include demographic, dietary, lifestyle and clinical information. Continuous variables will
be summarized using Mean and SD; categorical variables will be summarised using counts and
percentages. To determine intervention group differences in repeated MDS and other end-point
measures generated by the study, we will use statistical techniques appropriate for longitudinal data
analysis e.g., linear mixed effects models. Initial examination of the correlation structure of the repeated
measures will help identify significant interactions between potential confounders and guide model
fitting. Linear models will be adjusted for covariates where appropriate and both unadjusted and
adjusted models will be presented. The difference in means will provide an estimate of the effect
of intervention and 95% confidence limits will be calculated to indicate its precision. If appropriate,
measurements will be logarithmically transformed prior to analysis and interpretation will be made in
ratio terms on the original scale. Statistical significance will be set at p ≤ 0.05. Process evaluation data
analysis will be presented in a separate manuscript.
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4. Discussion
Supporting adoption and maintenance of a healthy diet such as the MD, which has been shown
to effectively reduce the risk of disease, should be a high public health priority for disease prevention.
Most trials evaluating the health impacts of a MD have been conducted in Mediterranean countries.
One exception is the MedLey study in older Australians that demonstrated improved CVD risk factors
(blood pressure, triglycerides, and F2-isoprostanes) as well as greater flow-mediated dilatation [57,58]
after a 6-month MD intervention. Dietary behaviour change was achieved in this study using intensive
methods: dietetic consultations and motivational interviewing at 3 and 6 months and every fortnight
in between, provision of written educational materials, sample menus and recipes, a daily food
checklist to help track compliance with the diet and provision of key foods [59]. While these
findings indicate that behaviour change towards a MD is achievable with a health professional
led intervention in a non-Mediterranean population, there is still much to learn regarding the most
cost-effective approaches to support MD behaviour change [60], and particularly, interventions to
support longer-term maintenance of newly adopted MD behaviours in non-Mediterranean countries.
This paper describes the protocol for the TEAM-MED trial to explore feasibility of a developed
peer support intervention for dietary behaviour change towards a MD, compared to another more
intensive method of support, in Northern Europeans at high CVD risk. The intervention has
been developed using a theory-based approach and is tailored to the needs of the target group
to promote dietary behaviour change. TEAM-MED benefits from including a range of objective
and subjective measures of diet adherence over 12 months, which will help to determine adoption
and maintenance of dietary behaviours consistent with a MD. TEAM-MED also incorporates a
comprehensive evaluation plan to determine acceptability and fidelity of intervention implementation
and will explore potential important mediators of dietary change in the population and these methods
will be more comprehensively described in a separate paper.
5. Conclusions
Findings from this study will generate important data for acceptability and feasibility of the peer
support intervention and the ease of adoption of MD in an ‘at risk’ group in a Northern European
population with low MD adherence. Ultimately, data generated here will be used to inform the design
of a larger scale RCT, where the clinical efficacy and cost-effectiveness of the peer support intervention
will be tested.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/15/6/1130/
s1, Table S1: SPIRIT checklist, Table S2: TEAM-MED Mediterranean Diet Score screener.
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